ESSA Pharma Plans $1.91 Per Share Distribution Before XenoTherapeutics Merger - Court Hearing Set

ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Approval of an Interim Order and Cash Distribution to Shareholders

SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, July 23, 2025 /PRNewswire/ -- ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX) today announced that, in connection with its previously announced business combination agreement with XenoTherapeutics, Inc. ("Xeno"), a non-profit biotechnology…

ESSA Pharma Plans $1.91 Per Share Distribution Before XenoTherapeutics Merger - Court Hearing Set

ESSA Pharma seeks court approval for $1.91 per share distribution ahead of XenoTherapeutics merger. August 5 hearing to determine shareholder payout. Get details.